JUNS - jupiterneurosciences.com Qarzning balans kapitallashuviga nisbati

Jupiter Neurosciences Inc (JUNS) grafik logotipi

Hozirgi qarzning kitob qiymatiga nisbati respirator patologiyalarga qarshi kurashayotgan onkologiya markazlari bilan hamkorlik sharoitida Jupiter Neurosciences Inc (JUNS) moliyaviy barqarorligini baholash imkonini beradi. Akademiklar bilan birgalikda olib borilayotgan miya yallig'lanishi mexanizmlarini tadqiq qilish va nevrologik kasalliklar terapiyasi uchun resveratrol platformasini ishlab chiqish strategik vektorni belgilaydi. Ushbu ko'rsatkich 0.00 darajasida qayd etilgan bo'lib, bu biznesning qarz yuklamasini real vaqt rejimida kuzatishga yordam beradi.

Jupiter Neurosciences (JUNS) - Balans qiymatiga qarzlar 04.12.2024dan 27.10.2026gacha

jupiterneurosciences.com (JUNS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Jupiter Neurosciences Inc|JUNS - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Jupiter Neurosciences Inc|JUNS - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Jupiter Neurosciences|JUNS - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati jupiterneurosciences.com|JUNS - Biznesning jami aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Jupiter Neurosciences Inc|JUNS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Jupiter Neurosciences|JUNS - Kompaniyaning jamlangan qarzdorligi|Balans kapitallashuviga qarzlar Jupiter Neurosciences Inc
Kompaniyaning fundamental tahlili:Jupiter Neurosciences Inc
Jupiter Neurosciences tovar namunasi

Hissiy aktivlarning ishonchliligini baholash kapital tuzilmasining barqarorligini tahlil qilishdan boshlanadi. Ushbu koeffitsiyent umumiy majburiyatlarni kapitalning balans qiymati bilan solishtirib, moliyaviy leveraj darajasini aniqlaydi. Jupiter Neurosciences Inc (JUNS) uchun laboratoriyalarni ekologiklashtirish va "yashil kimyo" bilan bog'liq xarajatlar muvozanatli moliyalashtirishni talab qiladi. Qarz olishning optimal darajasi ESG standartlariga rioya qilgan holda daromadlilikni saqlab qoladi. Kompaniyaning joriy qarzning balans kapitalizatsiyasiga nisbati ushbu muvozanatni ob'ektiv ravishda aks ettiradi.

Jupiter Neurosciences Inc (JUNS) raqobatchilari

Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|XENE (Xenon Corp) - Balans qiymatiga qarzlar|Viking Therapeutics (VKTX) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitaliga nisbati supernus.com (SUPN)|Qarzning balans qiymatiga nisbati CPRX|Balans kapitallashuviga qarzlar DNLI (Denali)|Harmony Pharma (HRMY) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Biohaven Corp BHVN|Balans kapitallashuviga qarzlar AMLX (Amylyx Pharmaceuticals)|trevitherapeutics.com (TRVI) - Sof aktivlarga qarzlar|PRAX - Qarzning balans qiymatiga nisbati|Anavex (AVXL) - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar CBLL (CeriBell Corp)|Balans qiymatiga qarzlar PRTA|Alector, Inc. (ALEC) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati annexonbio.com ANNX|Qarzning balans qiymatiga nisbati Omeros|Neurogene Inc - Qarzning sof aktivlarga nisbati|AC Immune Corp (ACIU) - Qarzning balans kapitallashuviga nisbati|VYGR - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar NMRA|Balans qiymatiga qarzlar scilexholding.com|TVGN (Tevogen Bio) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar ACOG|Cognition Therapeutics (CGTX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati IKT (Inhibikase Pharma)|SAVA: Qarzning balans kapitallashuviga nisbati|Assertio Holdings - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati COYA (Coya)|VTGN - Sof aktivlarga qarzlar|OVID (ovidrx.com) - Balans kapitallashuviga qarzlar|Acumen Pharmaceuticals, Inc (ABOS) - Qarzning balans qiymatiga nisbati|CRVO: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Alterity Therapeutics Ltd|Clene Inc. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar PEPG (pepgen.com)|RLMD - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Annovis Bio Corporation ANVS|GRCE: Balans kapitallashuviga qarzlar|AIFF - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar KLTO|NRSN (NeuroSense Therapeutics Ltd.) - Balans qiymatiga qarzlar|RVPH: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar MetaVia, Inc. (MTVA)|NeurAxis, Inc. (NRXS) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati heliusmedical.com (HSDT)|Balans kapitallashuviga qarzlar PASG|Neuphoria Therapeutics, Inc. - Sof aktivlarga qarzlar|Minerva Neurosciences Corp (NERV) - Qarzning balans kapitallashuviga nisbati|ATHA - Qarzning balans qiymatiga nisbati|ADXN (Addex Therapeutics) - Balans kapitallashuviga qarzlar|ALZN (Alzamend Neuro) - Qarzning balans qiymatiga nisbati|Cyclerion Therapeutics Inc. (CYCN) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitaliga nisbati Protagenic (PTIX)|Qarzning balans qiymatiga nisbati KTTA|Balans kapitallashuviga qarzlar CRGT (cortigent.com)|ATXI - Qarzning balans kapitallashuviga nisbati|brainstorm-cell.com - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati CARA (Cara Therapeutics)|CHRO: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati eliemtx.com|Intra-Cellular Therapies, Inc. (ITCI) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar LBPH (Longboard Pharmaceuticals)|Balans qiymatiga qarzlar marinuspharma.com (MRNS)|Qarzning balans qiymatiga nisbati NKGN|Balans kapitallashuviga qarzlar NRBO (NeuroBo Pharmaceuticals Inc)|Qarzning balans kapitallashuviga nisbati Sage Therapeutics, Inc|Synaptogenix, Inc - Qarzning sof aktivlarga nisbati|TRVN (Trevena, Inc.) - Qarzning balans kapitallashuviga nisbati|VIGL: Balans qiymatiga qarzlar|WENA - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitaliga nisbati Cerevel Therapeutics Inc